Skip to content

Clinical trials

Completed Phase 2 Prostatic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Prostatic Neoplasms Phase: Phase 2 Status: Completed Clear all

743 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
200026
200132
200229
200339
200443
200542
200641
200745
200836
200928
201028
201133
201242
201336
201442
201521
201622
201730
201829
201917
202012
202117
20226
20234
20246
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed743

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)68
Memorial Sloan Kettering Cancer Center22
M.D. Anderson Cancer Center19
University Health Network, Toronto17
Dana-Farber Cancer Institute15
Alliance for Clinical Trials in Oncology14
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins13
University of Washington12
AstraZeneca11
Barbara Ann Karmanos Cancer Institute10

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Prostatic Neoplasms743
Neoplasm Metastasis36
Neoplasms31
Breast Neoplasms16
Carcinoma, Non-Small-Cell Lung10
Lung Neoplasms10
Colorectal Neoplasms8
Ovarian Neoplasms7
Adenocarcinoma5
Genital Neoplasms, Male5

Trials

Showing 1 to 25 of 743. Each trial links to its page on Pharma Observatory.

643 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.